Door Pharma

Door Pharma is a discovery phase biotech company that focuses on virus structural proteins as antiviral targets. The hypothesis underlying our work is that formation of an infectious virus requires the right interplay between viral components.

Door Pharma is a company in lifetech based in Indianapolis, IN.

Profile

"Door Pharma is a pioneering biotech company in the health and lifetech industries, focusing on utilizing virus structural proteins as antiviral targets. The company's research is centered around the crucial role of viral structural proteins in the formation of infectious viruses. By targeting these proteins, Door Pharma aims to disrupt the interplay necessary for viral contagion. Virus structural proteins play a vital role in the structural integrity and lifecycle of viruses, making them key actors in the infectious process. Door Pharma's innovative approach seeks to identify and exploit vulnerabilities in these proteins to prevent the formation of functional viruses. Through their cutting-edge research, Door Pharma is contributing to the development of novel antiviral strategies that have the potential to revolutionize the treatment and prevention of viral infections."

Within the lifetech space, the company focuses on its core offering rather than a broad product line.

Indianapolis, IN is where the company is located.

Its current recorded stage is Plug and Play portfolio startup.

Website: doorpharma.com